Walter E. Washington Convention Center
Washington, D.C.
May 16-19, 2022


  • Booth: 136

GenoSafe provides analytical testing services for the evaluation of quality, safety and efficacy of Gene and Cell therapy candidates including :

  • GLP biodistribution, shedding and immunogenicity studies ;

  • QC testing, such as viral titration, safety and potency/efficacy testing ;

  • GCP bioanalysis of patient samples, including immunogenicity, shedding and gene expression studies.

GenoSafe brings more than 15 years of experience in the development, qualification and validation of key analytical methods for product and sample testing.